Abstract: Metal complexes of dichloro-tetramorpholino-cyclophosphazatriene containing divalent cations such as Ni(II), Co(II), and Mn(II) have been prepared and characterised by standard physico-chemical procedures (elemental chemical analysis, IR and UV-VIS spectra, conductimetric measurement). The newly synthesised compounds possessed antifungal activity against Aspergillus and Candida spp., some of them showing effects comparable to ketoconazole (with minimum inhibitory concentrations in the range of 2-30 ktg/mL) but being generally less active as compared to the azole. Best activity was detected against C. albicans, and worst activity against A. niger. The mechanism of action of these compounds probably involves inhibition of ergosterol biosynthesis, and interaction with lanosterol-14-o-demethylase (CYP51A 1), since reduced amounts of ergosterol were evidenced by means of HPLC in cultures of the sensitive strain A.
Introduction
Recent developments in the chemistry of phosphazenes were focused on the synthesis of novel types [1] [2] [3] [4] of hnear, cychc or polymeric such denvauves and on their applcaUon as precursors for obtamng matera s with special properties 5-8.
The study of the co-ordination chemistry of cyclophosphazene derivatives is of considerable interest because of the high versatility of these compounds as ligands, and the putative applications as catalysts of the obtained metal complexes 9. Although the unsubstituted cyclophosphazene behaves as a poor ligand towards transition cations, the presence of moieties containing different heteroatoms attached on the cyclophosphazene ring highly increases their affinity for metal ions q4. Few metal complexes containing cyclophosphazene derivatives Results and Discussion
The ligand L probably acts polydentately in its metal complexes, due to the presence of several exocyclic nitrogen, oxygen and chlorine as well as three endocyclic nitrogen atoms in its molecule. To establish the electronic density of different donor atoms present in the ligand, the dichloro-tetramorpholinocyclophosphazatriene has been investigated with the Hyperchem programme.
-5 As seen from Fig.1 the morpholine nitrogen and oxygen atoms have partial charges of-0.899 and -0.265, respectively, the chlorine atoms of-0.636, whereas the endocyclic nitrogens of the phosphazene ring, although the most negativelycharged (with a partial electronic density in the range-1.882/-1.926), are probably less available for interaction with the metal ions due to the strong steric hindrance. From data of Fig. 1 , it can be estimated that in the mononuclear complexes 1, 4 and 7 the ligand L probably acts bidentately by means of two morpholine nitrogen atoms bound to two different phosphorus atoms, while in the di-and trinuclear complexes 2, 3, 5, and 6, all the exocyclic nitrogen atoms of the ligand are involved in co-ordination of the metal ions As seen from data of Table l, the prepared complexes are non-electrolytes (1, 2, 4, 5, and 7), or 1:2 electrolytes (complexes 3 and 6). Co(II) complexes show two large bands, v2 and v3, assigned to the spin allowed transitions 4A2--)aT(F and 4A2----)4T2, respectively. The v3 band is spin-forbidden and only rarely observed in tetrahedral Co(II)
complexes.
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For the complex 7 and also, for the cobalt complexes reported here, the electronic spectra in the visible region appear quite similar to those of the corresponding chloro-complexes of the type MC1, x. 28 An octahedral geometry has also been assumed for compounds 6 and 7, based on their electronic spectra (table 2) . Table 3 .
From the data of Table 3 , one should note that the new compounds 1-7 reported here represent a new class of antifungals, with a lower biological activity as compared to that of ketoconazole against the investigated organisms, but with MIC-s in the micromolar range, which might induce strong antifungal effects.
The most active derivative was the Mn(II) complex 7, followed by the Ni(II) and the Co(II) complexes (the less active). Generally the mononuclear complexes were more active than the dinuclear ones, which in turn were more active than the trinuclear ones. Candida was most susceptible to inhibition, followed by A. flavus, whereas A. niger was the most resistant to this type of antifungals. In this respect, the complex derivatives parallel the biological activity of ketoconazole, although they are much less active.
Ketoconazole 8 is known to act as an inhibitor of lanosterol 14-o-demethylase (CYP51A1), a microsomal cytochrome P-450 dependent enme system belonging to a gene superfamily involved in sterol 18 21 biosynthesis in fungi, plants and animals. CYP51A1 has been shown to catalyse the conversion of lanosterol to the 14-desmethylated derivative, ergosterol, through a complicated oxidative sequence. Its inhibition in fungi causes the depletion of ergosterol and accumulation of 14-methylsterols in the membrane of the cells, disturbing thus membrane function and causing the death of these organisms. 8'19 In order to test the hypothesis that the compounds reported here act as ergosterol biosynthesis inhibitors, similarly to the azole antifungals, the amounts of ergosterol present in C. albicans cultures after treatment with different concentrations of new the inhibitor 7 and ketoconazole 8, a potent CYP51A1 inhibitor, 9 have been determined by means of a HPLC method (Table 4) . 22 These data show that at low concentrations of inhibitor, around 66-96 % of ergosterol (as compared to the amount of sterol formed in cultures in which inhibitors have not been added, and which was considered 100%) is still synthesised. By increasing the concentrations of inhibitors used in the experiments, the amount of synthesised ergosterol decreased dose-dependently. A similar effect has been observed for the well-known CYP51A1 inhibitor Ketoconazole 8 as well as for the complex 7 synthesised in the present study. These data allow us to propose a similar mechanism of action for the two classes of antifungal compounds, i.e., the inhibition of lanosterol-14-c-demethylase, although it is not improbable that our compounds might interfere with other enzyme(s) involved in the ergosterol biosynthetic pathway.
